Recently, circulating VEGF levels have been reported to be a reliable and noninvasive marker of angiogenic activity and were shown to be independent prognostic factors which are correlated with survival in various malignant neoplasms [17], but fewer studies were carried out to evaluate its circulating level. This evidence concerns the gene VEGFA and cancer.